Article

  • The EMBO Journal (1999) 18, 2106 - 2118
  • doi:10.1093/emboj/18.8.2106

The p16INK4a tumour suppressor protein inhibits alphavbold beta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbold beta3 to focal contacts

Robin Fåhraeus1 and David P. Lane1

  1. CRC Laboratories, Department of Biochemistry, University of Dundee, Dundee DD1 4HN, UK

Correspondence to:

Robin Fåhraeus, E-mail: rfahraeus@bad.dundee.ac.uk

Received 2 November 1998; Accepted 23 February 1999; Revised 8 February 1999


Expression of full-length p16INK4a blocks alphavbeta3 integrin-dependent cell spreading on vitronectin but not collagen IV. Similarly, G1-associated cell cycle kinases (CDK) inhibitory (CKI) synthetic peptides derived from p16INK4a, p18INK4c and p21Cip1/Waf1, which can be delivered directly into cells from the tissue culture medium, do not affect non-alphavbeta3-dependent spreading on collagen IV, laminin and fibronectin at concentrations that inhibit cell cycle progression in late G1. The alphavbeta3 heterodimer remains intact after CKI peptide treatment but is immediately dissociated from the focal adhesion contacts. Treatment with phorbol 12-myristate 13-acetate (PMA) allows alphavbeta3 to locate to the focal adhesion contacts and the cells to spread on vitronectin in the presence of CKI peptides. The cdk6 protein is found to suppress p16INK4a-mediated inhibition of spreading and is also shown to localize to the ruffling edge of spreading cells, indicating a function for cdk6 in controlling matrix-dependent cell spreading. These results demonstrate a novel G1 CDK-associated integrin regulatory pathway that acts upstream of alphavbeta3-dependent activation of PKC as well as a novel function for the p16INK4a tumour suppressor protein in regulating matrix-dependent cell migration.

  • Keywords:

    • alphavbeta3 integrin,
    • cancer,
    • integrin regulatory pathway,
    • p16INK4a tumour suppressor protein